bioRxivNeurosciencePreprint
Protecting synapses from amyloid β-associated degeneration by manipulations of Wnt/planar cell polarity signaling
Bo FengiD, Andiara E. FreitasiD, Runyi TianiD, Yeo Rang Lee, Akumbir S. Grewal, Jingyi WangiD, Yimin ZouiD
Abstract
Synapse loss is an early event in Alzheimers disease and is thought to be associated with amyloid pathology and caused by Amyloid {beta} (A{beta}) oligomers. Whether and how A{beta} oligomers directly target signaling pathways for glutamatergic synapse maintenance is unknown. Glutamatergic synapse development is controlled by the opposing functions of Celsr3 and Vangl2, core components of the Wnt/planar cell polarity (PCP) signaling pathway, functioning directly in the synapses. Celsr3 promotes synapse formation, whereas Vangl2 inhibits synapse formation. Here we show that oligomeric A{beta} binds to Celsr3 and assists Vangl2 in disassembling synapses by disrupting the intercellular Celsr3/Frizzled3-Celsr3 complex, essential for PCP signaling. Together with Vangl2, a Wnt receptor, Ryk, is also required for A{beta} oligomer-induced synapse loss in a mouse model of Alzheimers disease, 5XFAD, where conditional Ryk knockout protected synapses and preserved cognitive function. Our study reveals a fine balance of Wnt/PCP signaling components in glutamatergic synapse maintenance and suggests that overproduced A{beta} oligomers may lead to excessive synapse loss by tipping this balance. Together with previous reports that an inhibitor of Wnt/Ryk signaling, WIF1, is found reduced in Alzheimers disease patients, our results suggest that the imbalance of PCP signaling in these patients may contribute to synapse loss in Alzheimers disease and manipulating Wnt/PCP signaling may preserve synapses and cognitive function.
- organism: mouse
- research focus: cell-cell communication
- research focus: differential expression
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synaptotoxic forms of amyloid-b and a-synuclein act through a common pathway.
Elena M. Ribé, Anshua Ghosh, … Richard Killick·bioRxiv·Feb 13, 2025
- Amyloid-β can activate JNK signalling via WNT-5A/ROR2 to reduce synapse formation in Alzheimer's disease.
Kevin Fang, Ehsan Pishva, … Steffen Scholpp·Journal of Cell SciencePeer-reviewed·Feb 1, 2025
- β-amyloid-driven synaptic depression requires PDZ protein interaction at AMPA-receptor subunit GluA3
Niels R. Reinders, Sophie J. F. van der Spek, … Helmut W. H. G. Kessels·bioRxiv·Oct 3, 2021
- Amyloid-β1-42 oligomers enhance mGlu5R-dependent synaptic weakening via NMDAR activation and complement C3aR/C5aR signaling
Ai Na Ng, Eric W. Salter, … Graham L. Collingridge·bioRxiv·Oct 24, 2022
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model
Núria Martín‐Flores, Marina Podpolny, … Patricia C. Salinas·eLifePeer-reviewed·Sep 25, 2023
- An increased excitation and inhibition onto CA1 pyramidal cells sets the path to Alzheimer's disease
Patrick H. Wehrle, Travis J. Rathwell, … Annalisa Scimemi·bioRxiv·May 27, 2025